Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 1
Submit an article Journal homepage
2,197
Views
21
CrossRef citations to date
0
Altmetric
research paper

MiR-1224-5p attenuates polycystic ovary syndrome through inhibiting NOD-like receptor protein 3 inflammasome activation via targeting Forkhead box O 1

Yan LiDepartment of Obstetrics and Gynecology, the First Affiliated Hospital of The Fourth Military Medical University, Xi’an, Shaanxi 710032, People’s Republic of ChinaView further author information
,
Nianling YaoDepartment of Obstetrics and Gynecology, the First Affiliated Hospital of The Fourth Military Medical University, Xi’an, Shaanxi 710032, People’s Republic of ChinaView further author information
,
Yan GaoDepartment of Obstetrics and Gynecology, the First Affiliated Hospital of The Fourth Military Medical University, Xi’an, Shaanxi 710032, People’s Republic of ChinaView further author information
,
Yunping WangDepartment of Obstetrics and Gynecology, the First Affiliated Hospital of The Fourth Military Medical University, Xi’an, Shaanxi 710032, People’s Republic of ChinaView further author information
,
Lu BaiDepartment of Obstetrics and Gynecology, the First Affiliated Hospital of The Fourth Military Medical University, Xi’an, Shaanxi 710032, People’s Republic of ChinaView further author information
,
Jia XuDepartment of Obstetrics and Gynecology, the First Affiliated Hospital of The Fourth Military Medical University, Xi’an, Shaanxi 710032, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Haixu WangDepartment of Obstetrics and Gynecology, the First Affiliated Hospital of The Fourth Military Medical University, Xi’an, Shaanxi 710032, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 8555-8569 | Received 22 Jul 2021, Accepted 24 Sep 2021, Published online: 21 Oct 2021

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Xiaoyuan Xu, Xiaohua Xu, Xiaoshuang Wang & Ling Shen. (2023) Baicalin suppress the development of polycystic ovary syndrome via regulating the miR-874-3p/FOXO3 and miR-144/FOXO1 axis. Pharmaceutical Biology 61:1, pages 878-885.
Read now
Xiaohua Li, Laifang Zhu & Yan Luo. (2022) Long non-coding RNA HLA-F antisense RNA 1 inhibits the maturation of microRNA-613 in polycystic ovary syndrome to promote ovarian granulosa cell proliferation and inhibit cell apoptosis. Bioengineered 13:5, pages 12289-12297.
Read now
Longlong Du, Xuefeng Li, Qimeng Gao, Puwei Yuan, Yindi Sun, Yingpu Chen, Bo Huang, Yu Deng & Baohui Wang. (2022) LncRNA nuclear receptor subfamily 2 group F member 1 antisense RNA 1 (NR2F1-AS1) aggravates nucleus pulposus cell apoptosis and extracellular matrix degradation. Bioengineered 13:2, pages 2746-2762.
Read now

Articles from other publishers (18)

Xiaolan Huang, Xiangmin Luo, Suzhen Huang, Xiaoqing Chen & Lingling Qiu. (2024) Inhibition of FoxO1 alleviates polycystic ovarian syndrome by reducing inflammation and the immune response. Functional & Integrative Genomics 24:1.
Crossref
Mingyan Ju, Zihan Wang, Weiwei Yang, Zhenhua Sui, Wenjing Wang, Kuikui Sun & Chenchun Ren. (2023) Improvement of Inflammation and Abnormal Vascularization by TSP1 Treatment Combined with ADSCs Transplantation in Mice with Induced Polycystic Ovary Syndrome. Advanced Biology 8:2.
Crossref
Danni Jiang, Yang Xu, Lin Yang, Pengfei Li, Xiaojuan Han, Qianni Li, Yang Yang & Lan Chao. (2024) Identification and validation of senescence-related genes in polycystic ovary syndrome. Journal of Ovarian Research 17:1.
Crossref
Solmaz Chamanara, Vahid Hozouri & Elnaz Irandoost. (2023) Inhibition of NLRP3 inflammasome—A potential mechanistic therapeutic for treatment of polycystic ovary syndrome?. Journal of Biochemical and Molecular Toxicology 38:1.
Crossref
Jiaqiong Lin, Zhihong Wu, Yingchun Zheng, Zongrui Shen, Zhongzhi Gan, Shunfei Ma, Yanhui Liu & Fu Xiong. (2023) Plasma-derived exosomal miRNA profiles reveal potential epigenetic pathogenesis of premature ovarian failure. Human Genetics.
Crossref
Zhenghong Zhang, Congjian Shi & Zhengchao Wang. (2023) The physiological functions and therapeutic potential of exosomes during the development and treatment of polycystic ovary syndrome. Frontiers in Physiology 14.
Crossref
Tian Peng, Chi Zhang, Wen-Jun Chen, Xue-Fei Zhao, Wei-Bo Wu, Wei-Ji Yang & Ruo-Jia Liang. (2023) Pyroptosis: the dawn of a new era in endometrial cancer treatment. Frontiers in Oncology 13.
Crossref
Kexin Wang & Yanhua Li. (2023) Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome. Frontiers in Endocrinology 14.
Crossref
Miaoxin Yang, Suyuan Liu, Jiangxue Cai, Xiaoxiao Sun, Chenxuan Li, Meiling Tan & Bin He. (2023) Bile acids ameliorates lipopolysaccharide-induced endometritis in mice by inhibiting NLRP3 inflammasome activation. Life Sciences 331, pages 122062.
Crossref
Xu Zheng, Dan Zhao, Ye Jin, Yang Liu & Da Liu. (2023) Role of the NLRP3 inflammasome in gynecological disease. Biomedicine & Pharmacotherapy 166, pages 115393.
Crossref
Jiying Chen, Zhiying Zhu, Shi Xu, Jing Li, Lilan Huang, Wenqing Tan, Yonggang Zhang & Yanli Zhao. (2023) HDAC1 participates in polycystic ovary syndrome through histone modification by regulating H19/miR-29a-3p/NLRP3-mediated granulosa cell pyroptosis. Molecular and Cellular Endocrinology 573, pages 111950.
Crossref
Salih Atalah Alenezi, Raheela Khan, Lindsay Snell, Shaimaa Aboeldalyl & Saad Amer. (2023) The Role of NLRP3 Inflammasome in Obesity and PCOS—A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences 24:13, pages 10976.
Crossref
Achsha Babu & Gnanasambandan Ramanathan. (2023) Multi-omics insights and therapeutic implications in polycystic ovary syndrome: a review. Functional & Integrative Genomics 23:2.
Crossref
Muhammad Sohaib Khan, Hee-Sun Kim, Ranhee Kim, Sang Ho Yoon & Sang Geon Kim. (2023) Dysregulated Liver Metabolism and Polycystic Ovarian Syndrome. International Journal of Molecular Sciences 24:8, pages 7454.
Crossref
Ying Wang, Jiyu Yang, Yu Wang, Yao Chen, Yiran Wang, Hongying Kuang & Xiaoling Feng. (2023) Upregulation of TXNIP contributes to granulosa cell dysfunction in polycystic ovary syndrome via activation of the NLRP3 inflammasome. Molecular and Cellular Endocrinology 561, pages 111824.
Crossref
Mohammad Reza Tabandeh, Sadegh Jozaie, Zohre Ghotbedin & Saad Gorani. (2022) Dimethyl itaconic acid improves viability and steroidogenesis and suppresses cytokine production in LPS-treated bovine ovarian granulosa cells by regulating TLR4/nfkβ, NLRP3, JNK signaling pathways. Research in Veterinary Science 152, pages 89-98.
Crossref
Prajna Bhandary, Prasanna Kumar Shetty, Lakshmi Manjeera & Prakash Patil. (2022) Hormonal, genetic, epigenetic and environmental aspects of polycystic ovarian syndrome. Gene Reports 29, pages 101698.
Crossref
Wei-hong Chen, Qiao-yi Huang, Zhi-yi Wang, Xuan-xuan Zhuang, Shu Lin & Qi-yang Shi. (2022) Therapeutic potential of exosomes/miRNAs in polycystic ovary syndrome induced by the alteration of circadian rhythms. Frontiers in Endocrinology 13.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.